# Undecimal Launches with $18M Seed Round

> Undecimal Bio secures $18M seed funding for mRNA delivery platform.
- Title: Undecimal Launches with $18M Seed Round · RuntimeWire
- Summary: Undecimal Bio secures $18M seed funding for mRNA delivery platform. Undecimal Bio raised $18 million in seed funding to develop its mRNA delivery platform…
- Keywords: undecimal, mrna, delivri, renovascular, seed round, cancer research uk, technology, Launches, 18M, Seed, Round, RuntimeWire
- Source: RuntimeWire — https://runtimewire.com/article/undecimal-launches-with-18m-erlich-reports-mouse-mrna-repres-ba06f0
- Author: RuntimeWire
- Published: 2026-10-15T18:21:36.402+00:00
- Read time: 1 min
- Topics: undecimal, mrna, delivri, renovascular, seed round, cancer research uk, technology, ai
## Undecimal Bio
Undecimal Bio announced an oversubscribed $18 million seed round to support DELiveri platform development and renovascular programs.
## Erlich's mRNA Findings
Erlich's mouse mRNA repression results do not establish human delivery, safety, or therapeutic efficacy for renovascular disease.
## Funding Details
The round was co-led by 4BIO Capital and IQ Capital with participation from Verve Ventures, Harel Tech, Entrée Capital, Kerna Ventures, and Saras Capital.
## Key takeaway

Undecimal Bio raised $18 million in seed funding to develop its mRNA delivery platform for renovascular disease.